Drug Profile
Research programme: calprotectin inhibitors - Kaneka/Teikyo University/Tokyo University
Latest Information Update: 08 Apr 2008
Price :
$50
*
At a glance
- Originator Kaneka; Teikyo University; Tokyo University of Science
- Developer Kaneka
- Class Alkaloids
- Mechanism of Action Leukocyte L1 antigen complex antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 28 Sep 1999 Preclinical development for Inflammation in Japan (Unknown route)